Błękit metylenowy! Prawda wyszła na jaw! Czy "zwykły barwnik" okaże się rewolucją? Hubert Czerniak

The speaker mentions this in passing while noting that the only other substance he knows that directly opposes nitric oxide is caffeine from black coffee. He does not elaborate on mechanism or dosage, but the statement is delivered as a practical, everyday countermeasure to the same NO problem that methylene blue addresses.

Czerniak claims that the 1992 “Molecule of the Year” campaign was a pharma‑funded narrative. He describes how the company Fazer (a name he says later became Viagra’s manufacturer) needed the public to be fascinated with nitric oxide so that sildenafil—a drug that boosts NO levels—could become a blockbuster. He then details cases where prolonged erections from sildenafil led to gangrene and penile amputation, and warns that taking nitroglycerin (which also donates NO) while using sildenafil can cause a fatal overload of free radicals, blocking mitochondrial oxygen metabolism and triggering a heart attack. The core argument is that while NO does acutely vasodilate, when its levels stay high it binds tightly to the iron in cytochrome c oxidase (Complex IV) and halts ATP production, making chronic elevated NO a hallmark of metabolic disease, not health.

Czerniak explains that the most common mitochondrial lesion in degenerative diseases is at Complex IV, where the final electron transfer to oxygen occurs. In conditions of high nitric oxide—present in inflammation, hypoxia, and smog exposure—the enzyme becomes choked. Methylene blue, because of its redox properties, can accept electrons earlier in the chain and deliver them directly to cytochrome c or to oxygen, forming water and generating ATP even when Complex IV is inhibited. Moreover, it chemically reduces the NO that is stuck to the oxidase, freeing the catalytic iron and restoring natural activity. This dual role makes methylene blue uniquely suited to counter the damage he attributes to chronic NO overload. He stresses that only pharmaceutical‑grade material (at least CDA purity) should be used, as technical dye may contain heavy metals.

Czerniak describes his own years‑long struggle with joint degeneration and limited stamina. Despite using anti‑inflammatory supplements and even intravenous vitamin C, he could not run more than a couple of lengths of a sports field without bending over, seeing spots, and gasping for air—what he calls a typical “elderly gentleman” phenomenon. He then began taking methylene blue (the “gumisiowy jagód” concentrate, his whimsical name for it). On the first trial, after running two field lengths, the dizziness was gone, and he went on to play several tennis sets. He emphasizes that he could now serve from above his head, not just underhand, and that this dramatic improvement was sustained. He attributes the previous symptoms to excess nitric oxide choking his mitochondria, and the recovery to methylene blue scouring out the NO.

Czerniak uses the example of a normobaric chamber where CO₂ is intentionally kept at 1.5–2% (60 times ambient) and explains that people entering such a chamber feel warmth because CO₂ powerfully dilates vessels, enhancing perfusion. He contrasts this with nitric oxide, which initially dilates but later poisons the mitochondria. He further points to the naked mole‑rat (golec piaskowy), a rodent that lives 16 times longer than similar‑sized animals, never gets cancer, and breathes a mixture of 6% CO₂ and 7% O₂ (compared to our 0.04% CO₂ and 21% O₂). This high‑CO₂, low‑oxygen environment, he argues, fuels its mitochondrial efficiency and longevity. The implication is that increasing CO₂ tolerance and reducing NO overload are keys to health.